| This seasoned trader loves two things:
- Unusual Options Activity
- Massive Trading Events
Considering that, it's no wonder he's bananas for biotech right now!
Because an aggressive "Desk Clearing" of FDA approvals is fueling what may be some of the easiest profits of 2021…
New studies from Harvard University and MIT state…
"U.S. Food and Drug Administration is approving drugs faster than ever."
The report notes…
"Approval spikes occur at the end of each calendar month" and before the "end of the year in a kind of 'desk-clearing' activity."
Dozens of stocks could pop in the next 61 days as the FDA clears their backlog of drug approvals.
And right now, one stock…
And with it… one FDA decision that could be worth upwards of $100 Million…
Will kick off this biotech bonanza!
|
|
| Matt Warder Fortune Research |
|
| A Fortune Research Publication |
|
| Disclaimer & Disclosures The information in this email is intended for informational purposes only and does not guarantee specific results as there is a high degree of risk involved with trading. Also, our traders are real traders and may have financial interests in the companies discussed. Please see our Terms and Conditions for more information.
|
|
|
|
|
|
This email was sent to penunggangbadai.moneyblog@blogger.com by WealthPress LLC | |
|
|
|
|
0 Response to "2 Things My Friend Loves About Options Trading"
Post a Comment